Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Cash flows from operating activities:
Net income	$ 168,129	$ 240,572
Depreciation and amortization	141,298	95,647
Decrease in operating capital	(59,870)	(60,938)
Other non-cash items	36,892	27,486
Net cash provided by operating activities	286,449	302,767
Cash flows from investing activities:
Purchases of property, plant and equipment	(184,713)	(177,936)
Net (payments for) proceeds from other investing activities	(1,178)	754
Insurance proceeds received	0	1,359
Net cash used in investing activities	(185,891)	(175,823)
Cash flows from financing activities:
Proceeds from long-term debt	714,300	1,362,900
Repayments of long-term debt	(924,329)	(1,363,061)
Net proceeds from (repayments of) short-term debt	131,548	(3,735)
Repurchase of common stock	(15,996)	(50,000)
Net (payments) proceeds related to share-based compensation awards	(5,696)	6,880
Excess tax benefit from share-based compensation awards	9,100	15,000
Purchase of shares from noncontrolling interests	(8,639)	0
Dividends on common stock	(1,448)	(1,436)
Distributions to noncontrolling interests	(816)	(1,678)
Payment of contingent consideration	(2,906)	(3,820)
Proceeds from construction allowance	710	8,865
Net cash used in financing activities	(104,172)	(30,085)
Effect of exchange rate changes on cash and cash equivalents	(4,603)	(466)
Net (decrease) increase in cash and cash equivalents	(8,217)	96,393
Cash and cash equivalents - beginning of period	25,222	77,393
Cash and cash equivalents - end of period	17,005	173,786
Supplemental disclosures of cash flow information:
Litigation settlement charge	$ 17,000	$ 0